Biosimilars explained – what is a biosimilar and should I prescribe them in practice?

Learning objectives:

  • What is a biologic and a biosimilar? Consider the complexity of biologics and how biosimilars are different from generic medicines. How is a biosimilar different from the reference biologic, and how this compares with batch-to-batch variations within the reference medicine
  • How are biosimilars developed? Consider the different stages including the comparative quality, non-clinical and non-clinical studies
  • How are biosimilars approved? Consider EMA’s approval process and their experience of biosimilars
  • What is NICE’s guidance on biosimilars implementation? Article: nice.org.uk/guidance/ktt15
  • Why should we use biosimilars? Consider the potential cost saving and the opportunity to improve access for new innovative medicines

Thursday 15th November 2018

12:05 - 12:35

Primary, Community & Specialist Care

Speakers

Speaker Details TBC

Our site is intended for UK Healthcare Professionals

Are you a UK Healthcare Professional?

We’re sending you to our partner charity’s site. 

DRWF provide information and support for people with diabetes and their friends & families